IT202200010583A1 - “Composizione nutraceutica o farmaceutica per l’infertilità maschile” - Google Patents

“Composizione nutraceutica o farmaceutica per l’infertilità maschile” Download PDF

Info

Publication number
IT202200010583A1
IT202200010583A1 IT102022000010583A IT202200010583A IT202200010583A1 IT 202200010583 A1 IT202200010583 A1 IT 202200010583A1 IT 102022000010583 A IT102022000010583 A IT 102022000010583A IT 202200010583 A IT202200010583 A IT 202200010583A IT 202200010583 A1 IT202200010583 A1 IT 202200010583A1
Authority
IT
Italy
Prior art keywords
nutraceutical
pharmaceutical composition
male infertility
infertility
male
Prior art date
Application number
IT102022000010583A
Other languages
English (en)
Inventor
Maio Umberto Di
Original Assignee
Neilos S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neilos S R L filed Critical Neilos S R L
Priority to IT102022000010583A priority Critical patent/IT202200010583A1/it
Publication of IT202200010583A1 publication Critical patent/IT202200010583A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
IT102022000010583A 2022-05-23 2022-05-23 “Composizione nutraceutica o farmaceutica per l’infertilità maschile” IT202200010583A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102022000010583A IT202200010583A1 (it) 2022-05-23 2022-05-23 “Composizione nutraceutica o farmaceutica per l’infertilità maschile”

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000010583A IT202200010583A1 (it) 2022-05-23 2022-05-23 “Composizione nutraceutica o farmaceutica per l’infertilità maschile”

Publications (1)

Publication Number Publication Date
IT202200010583A1 true IT202200010583A1 (it) 2023-11-23

Family

ID=83080958

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000010583A IT202200010583A1 (it) 2022-05-23 2022-05-23 “Composizione nutraceutica o farmaceutica per l’infertilità maschile”

Country Status (1)

Country Link
IT (1) IT202200010583A1 (it)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001084961A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CN102511664A (zh) * 2012-01-16 2012-06-27 天津农学院 鱼油类饲用添加剂及其生产方法
WO2017125918A1 (en) * 2016-01-18 2017-07-27 Amorphical Ltd. Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions
WO2021099976A1 (en) * 2019-11-19 2021-05-27 Neilos S.r.l. A nutraceutical or pharmaceutical composition comprising iron pyrophosphate for use in the treatment and/or prevention of conditions or diseases characterized by iron deficiency
WO2021111404A1 (en) * 2019-12-04 2021-06-10 Alesco S.R.L. Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001084961A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CN102511664A (zh) * 2012-01-16 2012-06-27 天津农学院 鱼油类饲用添加剂及其生产方法
WO2017125918A1 (en) * 2016-01-18 2017-07-27 Amorphical Ltd. Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions
WO2021099976A1 (en) * 2019-11-19 2021-05-27 Neilos S.r.l. A nutraceutical or pharmaceutical composition comprising iron pyrophosphate for use in the treatment and/or prevention of conditions or diseases characterized by iron deficiency
WO2021111404A1 (en) * 2019-12-04 2021-06-10 Alesco S.R.L. Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Milk and Dairy Products in Human Nutrition : Production, Composition and Health", 10 June 2013, JOHN WILEY & SONS, INC., ISBN: 978-1-118-53420-5, article FRÉDÉRIC GAUCHERON: "Milk Minerals, Trace Elements, and Macroelements", pages: 172 - 199, XP055610514, DOI: 10.1002/9781118534168.ch9 *
BEIGI HARCHEGANI ASGHAR ET AL: "Possible mechanisms for the effects of calcium deficiency on male infertility", INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 1 January 2019 (2019-01-01), Iran, pages 267 - 272, XP093005422, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186280/pdf/Int-J-Fertil-Steril-12-267.pdf> [retrieved on 20221206], DOI: 10.22074/ijfs.2019.5420 *
DATABASE Biosis [online] 1 January 1991 (1991-01-01), PATNAIK S. M. ET AL: "EFFECT OF CALCIUM SALTS AND RELATED SUBSTANCES ON THE MOTILITY AND VIABILITY EJACULATED HUMAN SPERMATOZOA IN-VITRO", XP093005588, retrieved from https://pubmed.ncbi.nlm.nih.gov/1794893/ Database accession no. PREV199293022888 *
MORTENSEN ALICJA ET AL: "Re?evaluation of lecithins (E 322) as a food additive", THE EFSA JOURNAL, vol. 15, no. 4, 1 April 2017 (2017-04-01), Parma, IT, XP055797065, ISSN: 1831-4732, DOI: 10.2903/j.efsa.2017.4742 *

Similar Documents

Publication Publication Date Title
CO2021003036A2 (es) Compuestos de anillo fusionado
CO2021005987A2 (es) Compuestos de anillo fusionado
BR112017012377A2 (pt) conjugados anticorpo-fármaco com inibidores de bcl-xl permeáveis à célula
MX2020004932A (es) Compuestos utiles para inhibir a cdk7.
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
CL2019001337A1 (es) Formulaciones farmacéuticas.
GB202019241D0 (en) Pharmaceutical composition
BR112021017350A2 (pt) Combinação de conjugado de anticorpo-derivado de pirrolobenzodiazepina e inibidor de parp
UY37941A (es) Derivados de bencimidazol y sus usos
BR112022008365A2 (pt) Inibidores de cd73
ITUA20162575A1 (it) Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
IT202200010583A1 (it) “Composizione nutraceutica o farmaceutica per l’infertilità maschile”
IT202200010592A1 (it) “Composizione nutraceutica o farmaceutica per l’infertilità maschile”
IT202200010277A1 (it) “Composizione nutraceutica o farmaceutica per l’infertilità maschile”
IT202200010280A1 (it) “Composizione nutraceutica o farmaceutica per l’infertilità maschile”
IT202200010274A1 (it) “Composizione nutraceutica o farmaceutica per l’infertilità maschile”
DK4153133T3 (da) Injicerbare farmaceutiske sammensætninger og anvendelser deraf
IT202200004958A1 (it) “Composizione nutraceutica o farmaceutica per il benessere renale”
IT202200008879A1 (it) “Composizione nutraceutica o farmaceutica per la salute cardiovascolare”
IT202200008867A1 (it) “Composizione nutraceutica o farmaceutica per la salute cardiovascolare”
IT202200008534A1 (it) “Composizione nutraceutica o farmaceutica per la salute cardiovascolare”
IT202200008537A1 (it) “Composizione nutraceutica o farmaceutica per la salute cardiovascolare”
CR20220587A (es) Formulaciones farmacéuticas
IT202200013696A1 (it) “Composizione nutraceutica o farmaceutica nell’ambito della menopausa”
CO2024005025A2 (es) Composiciones líquidas orales de enzalutamida